Targeting proteins directly involved in collagen synthesis, such as collagen type l alpha (COL1A1) and COL3A1, is an alternative way of targeting excessive collagen synthesis in myocardial fibrosis. The gene discussed is COL3A1; the disease is Myocardial fibrosis.